Article info

other Versions

PDF
Original article
Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

Authors

  1. Correspondence to Dr C Janneke van der Woude, Department of Gastroenterology and Hepatology, Erasmus MC Rotterdam, ‘s Gravendijkwal 230, Rotterdam 3015 CE, The Netherlands; c.vanderwoude{at}erasmusmc.nl
View Full Text

Citation

Dewint P, Hansen BE, Verhey E, et al
Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

Publication history

  • Received 9 January 2013
  • Revised 22 February 2013
  • Accepted 22 February 2013
  • Published in print 22 March 2013.
  • Published online 23 March 2013.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.